600351.SH
Yabao Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 6.78
−1.31%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 6.61
From 52W high−6.74%
Volume16.25M
Market capCNY 4.69B
P/E (TTM)14.7x
P/S (TTM)2.1x
Div yield8.32%
Key dataSep 18, 2026
Open
CNY 6.61
From 52W high
−6.74%
Volume
16.25M
Market cap
CNY 4.69B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
7.3x
P/E (TTM)
14.7x
RSI (14)
43.9
MomentumView details →
1D Return
−1.31%
YTD Return
+1.85%
Similar companies
Latest newsMore news →
Shanxi Yabao Investment Group, controlling shareholder of Yabao Pharmaceutical, completed a stock pledge repo transaction, raising its cumulative pledged shares to 38.45 million shares, or 40.77% of its holding and 5.56% of the company's total share capital.5d agoYabao Pharmaceutical repurchased 200,000 shares for the first time on September 11, 2026, at 6.58-6.59 yuan per share for a total of 1.317 million yuan, under a 100-200 million yuan buyback program to cancel shares and reduce registered capital.10d agoYabao Pharmaceutical adjusted the upper limit of its share buyback price to 6.75 yuan per share, effective from September 1, 2026, due to the implementation of the 2026 interim dividend distribution.24d ago